Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Toyooka

Showing results (471-480 of 537) with videos related to

Pageof 54
Sort By:
Scientific Reports|December 24, 2016
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathwayTomoaki Ohtsuka, Masakiyo Sakaguchi, Hiromasa Yamamoto, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 13, 2023
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancerFumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
International Journal of Molecular Sciences|December 10, 2021
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance DevelopmentMiwa Fujihara, Tadahiko Shien, Kazuhiko Shien, et al.
Surgery Today|April 19, 2023
Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022Hisashi Oishi, Yoshinori Okada, Masaaki Sato, et al.
Cancer Immunology Research|July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor ImmunityYuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Transplantation and Cellular Therapy|December 22, 2025
Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell TransplantationAkira Yamamoto, Nobuharu Fujii, Keisuke Seike, et al.
Oncology Research|September 20, 2017
β-1,3-Galactosyl-<i>O</i>-Glycosyl-Glycoprotein β-1,6-<i>N</i>-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer MotilityI Wayan Sumardika, Chen Youyi, Eisaku Kondo, et al.
Acta Medica Okayama|December 22, 2022
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer PatientsYuko Abe, Naruto Taira, Kosuke Kashiwabara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi, et al.
Annals of Surgical Oncology|June 24, 2023
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After SurgeryToshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, et al.
Pageof 54

Showing results (471-480 of 537) with videos related to

Sort By:
Pageof 54
Scientific Reports|December 24, 2016
Interaction of cytokeratin 19 head domain and HER2 in the cytoplasm leads to activation of HER2-Erk pathwayTomoaki Ohtsuka, Masakiyo Sakaguchi, Hiromasa Yamamoto, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 13, 2023
Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancerFumiaki Takatsu, Ken Suzawa, Shuta Tomida, et al.
International Journal of Molecular Sciences|December 10, 2021
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance DevelopmentMiwa Fujihara, Tadahiko Shien, Kazuhiko Shien, et al.
Surgery Today|April 19, 2023
Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022Hisashi Oishi, Yoshinori Okada, Masaaki Sato, et al.
Cancer Immunology Research|July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor ImmunityYuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Transplantation and Cellular Therapy|December 22, 2025
Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell TransplantationAkira Yamamoto, Nobuharu Fujii, Keisuke Seike, et al.
Oncology Research|September 20, 2017
β-1,3-Galactosyl-<i>O</i>-Glycosyl-Glycoprotein β-1,6-<i>N</i>-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer MotilityI Wayan Sumardika, Chen Youyi, Eisaku Kondo, et al.
Acta Medica Okayama|December 22, 2022
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer PatientsYuko Abe, Naruto Taira, Kosuke Kashiwabara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung CancerHirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi, et al.
Annals of Surgical Oncology|June 24, 2023
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After SurgeryToshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, et al.
Pageof 54